Post-marketing Safety Measures

• Outline
• Scientific Research and Analyses
• Provision of Information Regarding Post-marketing Safety
  • Drugs
    • Risk Management Plan (RMP)
    • The Yellow Letter / Blue Letter
    • Safety Information Announced by MHLW
    • PMDA Risk Communications
    • Revisions of PRECAUTIONS
    • MHLW Pharmaceuticals and Medical Devices Safety Information
    • PMDA Alert for Proper Use of Drugs
    • Notifications Related to Safety Measures
    • English Translated Package Inserts
  • Medical Devices
    • PMDA Risk Communications
    • Revisions of PRECAUTIONS
    • Notification on Self-inspection
    • PMDA Alert for Proper Use of Medical Devices
    • PMDA Alert for Proper Use of Medical Devices (for patients)
    • Notifications Related to Safety Measures
  • Regenerative Medical Products
    • PMDA Risk Communications
    • Revisions of PRECAUTIONS
    • Notifications Related to Safety Measures
  • In Vitro Diagnostics
    • Notification on Self-inspection
    • Notifications Related to Safety Measures
  • PMDA Medical Safety Information
  • Information Regarding Newly Introduced Electronic Package Inserts
• Regulatory Information
• Public comments